CTRI/2021/07/034543尚未招募4 期
Topical amphotericin via intranasal route in covid positive patients at risk for invasive fungal sinusitis
Department of ENT0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •pre-existing diabetes mellitus at the time of admission
- •- in those without diagnosed diabetes at baseline, a fasting or random blood glucose level > 200 mg/ dl at any time point during admission
- •- patients who have received >=6 mg/day of Dexamethasone or >=30mg/day of methylprednisolone
- •- patients receiving immunomodulators for at least 24 hours
- •- patients receiving systemic anti-bacterial drugs
- •- patients with hematologic malignancies
- •- receiving bone marrow transplant/ systemic chemotherapy/ HIV-AIDS/ immunosuppressive therapy after organ transplant
排除标准
- •1. COVID 19 patients with evidence of mucor mycosis at screening or randomization
- •2. COVID 19patients with features of invasive fungal sinusitis at screening or randomization
研究者
相似试验
招募中
1 期
Intraocular Amphotericin B and Voriconazole in fungal Keratitis treatmentRBR-6rvjd2Departamento de Oftalmologia Universidade Federal de São Paulo
已完成
不适用
A novel drug combination and route for COVID-19 treatmentCorona virusPACTR202101875903773Hazem Elsersy200
已完成
2 期
Effects of intranasal amphotericin-B Irrigation on recurrence of massive nasal polyposisnasal polyposis.Nasal polypIRCT138706101138N1Guilan University of Medical Sciences96
进行中（未招募）
不适用
Efficacy of intranasal administration of haloperidol compared to intramuscular administration in agitated schizophrenic patientsEUCTR2014-001157-17-ESFundació Parc Taulí40
进行中（未招募）
1 期
Does subcutaneously(SC) administered of anakinra achieve good penetration in blood and result in reduce inflammation in patients with SARS-CoV-19?Suspected or confirmed SARS-CoV-2 infection (confirmed by RNA-PCR)MedDRA version: 23.0Level: PTClassification code 10051905Term: Coronavirus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2020-001636-95-GBniversity of Manchester40